Recruitment unclearEUCTR 2019-001989-15

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Followed by an Open-Label Extension to Evaluate the Efficacy and Safety of Fremanezumab for Preventive Treatment of...

This historical record does not confirm current site availability.

Historical research recordMultiple countriesDepression

The study in practice

Understand this study

What is this study about?

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

Listed locations: Czechia · Finland and 5 more locations
Study phase: Phase 4

What to know before participating

A point to clarify

This is historical registry information. What is the current study status and protocol?

Study clarity

Things to check before joining

Study start dateNot clearly listed

Recruitment status: Recruitment unclear
Enrollment listed in the registry: 340
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.
Sponsor type: Pharmaceutical company
Study type: Biological
Intervention type: BIOLOGICAL
Study phase: Phase 4
Locations: France, Czechia, Finland, ...
Age range: Not clearly listed
Official registry ID: EUCTR 2019-001989-15
Official title: Show the full official title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Followed by an Open-Label Extension to Evaluate the Efficacy and Safety of Fremanezumab for Preventive Treatment of...

Questions about this study?

The HopeStage team will email you.

Recruitment & locations

Status unknown

Czechia · Finland · France

4 more locations

Germany
Greece
Italy
Spain

Registry details

Historical country statuses

Czechia — Completed
Germany — Completed
Spain — Ongoing
Finland — Completed
France — Completed
Greece — Completed
Italy — Completed

A listed location does not confirm current availability.

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Teva Branded Pharmaceutical Products R&D, Inc., a pharmaceutical company.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me